Clinic file

Big Easy Weight Loss

Reviewed by Editorial review in progress · Last updated 2026-06-13

The bottom line

No verdict issued yet.

Big Easy Weight Loss is a New Orleans, Louisiana based telehealth clinic (soft-launched April 2024, first official day May 4, 2024) selling compounded semaglutide and tirzepatide via physician-led intake. It publicly lists six named compounding pharmacy partners on a dedicated Pharmacy Partners page, labeling Apothecary Pharma and BPI Labs as 503B and OptioRx, Hallandale, Miller's, and Boudreaux's New Drug Store as 503A. The community report that prescriptions are filled by Hallandale (503A) and Apothecary (503B) is consistent with the clinic's own page; however the clinic discloses multiple partners (and references roughly 7 main partners plus access to about two dozen more), so a single filler is not identified. The community detail that Apothecary's 503B product is dispensed by 'NewLifeRx' could not be verified: NewLifeRx is not mentioned on Big Easy's site or found in public sources reviewed. The clinic states it has no common ownership with any pharmacy. Pricing, refund, and subscription terms below are from the clinic's own pages and were not independently audited.

The supply chain

You buy fromBig Easy Weight LossThe brand: marketing, checkout, and the subscription.

Your clinician works forBig Easy Weight LossNo contract medical group found on the clinic's own pages.

Your prescription is filled byApothecary, BPI LabsNamed by the clinic's own disclosure — profiled in our pharmacy directory.

Licensed where you live?Check your stateEvery fill depends on the pharmacy holding a license in your state — verified below, state board by state board.

What checks out

No gate criteria passed yet.

What to watch

No terms of service or medication refund policy is published (the sitemap carries only a HIPAA & Privacy Notice, and the Billing FAQ page renders no content); the only stated refund is a membership refund if the physician does not prescribe.

Big Easy Weight Loss's own Pharmacy Partners page names Apothecary Pharma and BPI Labs among its 503B partners. Both carry recent FDA warning letters: Apothecary a December 2025 letter over insanitary sterile production, and BPI Labs a March 2025 letter plus a recall recommendation on the same grounds. A warning letter is not a shutdown order and does not by itself disqualify a pharmacy here, but it is a documented FDA finding worth weighing. The clinic discloses multiple pharmacy partners rather than a single filler, so not every patient is necessarily routed to either.

Trustpilot review integrity

Review integrity concern

100% of this company's reviews are organic (unprompted) — above our 40% threshold, the pattern most consistent with review gaming.

Score: 4.7 / 5 across 31 reviews (trailing 12 months)
Review source: 100% organic (unprompted) · 0% verified or invited (company-sent, post-transaction)
OrganicVerified / invited

Source: Trustpilot's own "Transparent Inviting" disclosure, company profile (accessed 2026-07-15).

Review integrity concern

100% of this company's Trustpilot reviews are organic (unprompted), above our 40% threshold. Verified and invited reviews both require a real completed transaction and the company choosing to send the invite, which makes them hard to fabricate at scale. A heavy skew toward organic, unprompted reviews is a known review-manipulation vector — it does not by itself disqualify a clinic, but it weighs against the verdict. See how we weigh this.

Corporate address transparency

Lists a real-looking operating address

Appears to be a real operating address, found on its BBB profile. The company does not publish this address on its own public pages.

Legal entity: Big Easy Weight Loss, LLC
Listed address: 2800 Veterans Blvd, Suite 220A, Metairie, LA 70002
Notes: BBB-accredited local operation licensed by the LA State Board of Medical Examiners.

Source: BBB Business Profile (accredited since 08-2024), Metairie LA (accessed 2026-07-19)

Who fills your prescription

Compounded only (no brand-name GLP-1 disclosed). Uses a mix of 503A state-licensed pharmacies and 503B FDA-registered outsourcing facilities; the clinic states it routes prescriptions across multiple independent pharmacies rather than a single filler, and that pricing and turnaround vary by pharmacy.

Apothecary503B · Apothecary Pharma, LLC · licensed in 0 of 50 states (unverified)No accreditations on file BPI Labs503B · BPI Labs, LLC · licensed in 0 of 50 states (unverified)FDA-registered 503B outsourcing facility (self-reported, unverified) · cGMP compliant per 21 CFR Part 210 and 211 (self-reported, unverified)

What it's actually like

Per the clinic's site: prospective patients start an online intake and have a consultation WITH a physician (the site states 'not an NP, PA, or intake nurse'), with ongoing physician access through the treatment duration. A $75 consultation charge applies, which the clinic says it credits toward treatment or refunds if the patient 'aren't a good fit.' If prescribed, medication ships from one of the listed compounding pharmacy partners (2-3 day turnaround claimed for several partners). Treatment is sold as 8-12 week packages (e.g., 12-week courses of compounded semaglutide or tirzepatide) with monthly installment payment available; medication, supplies (syringes, alcohol pads), and shipping are included.

How we review. Every clinic must clear two gates: a credible compounding pharmacy, licensed in every state it ships to, and a clinic that supports long-term patient success. We pay for our own access and accept no payment, referral fees, or coupon arrangements from anyone we cover. See the methodology.